Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Attenuation of Simian Varicella Virus Infection by Enhanced Green Fluorescent Protein in Rhesus Macaques.

Mahalingam R, Kaufer BB, Ouwendijk WJD, Verjans GMGM, Coleman C, Hunter M, Das A, Palmer BE, Clambey E, Nagel MA, Traina-Dorge V.

J Virol. 2018 Mar 14;92(7). pii: e02253-17. doi: 10.1128/JVI.02253-17. Print 2018 Apr 1.

PMID:
29343566
2.

Simian Varicella Virus Is Present in Macrophages, Dendritic Cells, and T Cells in Lymph Nodes of Rhesus Macaques after Experimental Reactivation.

Traina-Dorge V, Doyle-Meyers LA, Sanford R, Manfredo J, Blackmon A, Wellish M, James S, Alvarez X, Midkiff C, Palmer BE, Deharo E, Gilden D, Mahalingam R.

J Virol. 2015 Oct;89(19):9817-24. doi: 10.1128/JVI.01324-15. Epub 2015 Jul 15.

3.

Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaques.

Traina-Dorge V, Sanford R, James S, Doyle-Meyers LA, de Haro E, Wellish M, Gilden D, Mahalingam R.

J Neurovirol. 2014 Oct;20(5):526-30. doi: 10.1007/s13365-014-0274-2. Epub 2014 Aug 20.

4.

T cells increase before zoster and PD-1 expression increases at the time of zoster in immunosuppressed nonhuman primates latently infected with simian varicella virus.

James SF, Traina-Dorge V, Deharo E, Wellish M, Palmer BE, Gilden D, Mahalingam R.

J Neurovirol. 2014 Jun;20(3):309-13. doi: 10.1007/s13365-014-0237-7. Epub 2014 Feb 19.

5.

Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA.

Monjure CJ, Tatum CD, Panganiban AT, Arainga M, Traina-Dorge V, Marx PA Jr, Didier ES.

J Med Primatol. 2014 Feb;43(1):31-43. doi: 10.1111/jmp.12088. Epub 2013 Nov 22.

6.

GeXPS multiplex PCR analysis of the simian varicella virus transcriptome in productively infected cells in culture and acutely infected ganglia.

Nagel MA, Choe A, Gilden D, Traina-Dorge V, Cohrs RJ, Mahalingam R.

J Virol Methods. 2013 Oct;193(1):151-8. doi: 10.1016/j.jviromet.2013.05.020. Epub 2013 Jun 11.

7.

T-cell infiltration correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus.

Ouwendijk WJ, Abendroth A, Traina-Dorge V, Getu S, Steain M, Wellish M, Andeweg AC, Osterhaus AD, Gilden D, Verjans GM, Mahalingam R.

J Virol. 2013 Mar;87(5):2979-82. doi: 10.1128/JVI.03181-12. Epub 2012 Dec 26.

9.

Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash.

Ouwendijk WJ, Mahalingam R, Traina-Dorge V, van Amerongen G, Wellish M, Osterhaus AD, Gilden D, Verjans GM.

J Neurovirol. 2012 Apr;18(2):91-9. doi: 10.1007/s13365-012-0083-4. Epub 2012 Mar 8.

10.

Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.

Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL.

Vaccine. 2012 Jan 20;30(5):959-68. doi: 10.1016/j.vaccine.2011.11.046. Epub 2011 Nov 23. Erratum in: Vaccine. 2012 Nov 6;30(48):6955. Dosage error in article text.

11.

Effect of time delay after necropsy on analysis of simian varicella-zoster virus expression in latently infected ganglia of rhesus macaques.

Mahalingam R, Traina-Dorge V, Wellish M, Deharo E, Golive A, Messaoudi I, Gilden D.

J Virol. 2010 Dec;84(23):12454-7. doi: 10.1128/JVI.01792-10. Epub 2010 Sep 22.

12.

Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation.

Mahalingam R, Traina-Dorge V, Wellish M, Deharo E, Singletary ML, Ribka EP, Sanford R, Gilden D.

J Neurovirol. 2010 Oct;16(5):342-54. doi: 10.3109/13550284.2010.513031.

13.

Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.

Traina-Dorge V, Pahar B, Marx P, Kissinger P, Montefiori D, Ou Y, Gray WL.

Vaccine. 2010 Sep 7;28(39):6483-90. doi: 10.1016/j.vaccine.2010.07.018. Epub 2010 Jul 21.

14.

SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

Sealy R, Zhan X, Lockey TD, Martin L, Blanchard J, Traina-Dorge V, Hurwitz JL.

Curr HIV Res. 2009 Sep;7(5):497-503.

15.

The simian varicella virus uracil DNA glycosylase and dUTPase genes are expressed in vivo, but are non-essential for replication in cell culture.

Ward TM, Williams MV, Traina-Dorge V, Gray WL.

Virus Res. 2009 Jun;142(1-2):78-84. doi: 10.1016/j.virusres.2009.01.013. Epub 2009 Feb 4.

16.

Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.

Ward TM, Traina-Dorge V, Davis KA, Gray WL.

J Gen Virol. 2008 Mar;89(Pt 3):741-50. doi: 10.1099/vir.0.83453-0.

17.

Simian varicella virus reactivation in cynomolgus monkeys.

Mahalingam R, Traina-Dorge V, Wellish M, Lorino R, Sanford R, Ribka EP, Alleman SJ, Brazeau E, Gilden DH.

Virology. 2007 Nov 10;368(1):50-9. Epub 2007 Jul 24.

19.
20.

Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.

Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ.

Clin Infect Dis. 2007 May 1;44(9):1229-34. Epub 2007 Mar 19.

PMID:
17407044

Supplemental Content

Loading ...
Support Center